NASDAQ:IBB   iShares Biotechnology ETF
0
Parabolic run was broken, followed by a reasonable bounce thanks to the ASCO. Historically speaking, the trend lines suggest the pullback area in due time. Healthcare has seen astronomical returns which can't be sustained. Long term though, this will continue in the up trend. This sector will prosper.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.